Events | 2020.05.25
HistoIndex's AI-based Digital Pathology Platform: A Validated Quantification Tool Recommended in the Guidelines for the Prevention and Treatment of Chronic Hepatitis B in China
SINGAPORE, May 24, 2020 /PRNewswire/ -- Singapore medtech company HistoIndex\'s AI-based stain-free digital pathology platform has long been established as a suitable tool for global clinical guidelines that outline the assessment, prevention and treatment of Chronic Hepatitis B (CHB)...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]itis-b-in-china-301064243.html
